P Moosmann|S Rusconi - JoVE Visualize

Showing results (51-60 of 109) with videos related to

Pageof 11

Sort By:

Science (New York, N.Y.)|February 11, 1994

Transcriptional activation modulated by homopolymeric glutamine and proline stretchesH P Gerber, K Seipel, O Georgiev, et al.

Minerva Anestesiologica|October 9, 2002

[Cornea donation: role of the local coordinator in monitoring and implementation]G Ciceri, S Vesconi, G Carparelli, et al.

European Journal of Biochemistry|May 1, 1992

Phycobilisome structure in the cyanobacteria Mastigocladus laminosus and Anabaena sp. PCC 7120M Glauser, D A Bryant, G Frank, et al.

Journal of Clinical Microbiology|March 7, 2001

In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposureS La Seta Catamancio, M P De Pasquale, P Citterio, et al.

AIDS Research and Human Retroviruses|October 27, 1998

Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individualsS Rusconi, S Santambrogio, A Di Marco, et al.

Antimicrobial Agents and Chemotherapy|April 1, 1994

Alternating versus continuous drug regimens in combination chemotherapy of human immunodeficiency virus type 1 infection in vitroT Mazzulli, S Rusconi, D P Merrill, et al.

Glycobiology|August 1, 1994

Carbohydrate receptor-mediated gene transfer to human T leukaemic cellsM Thurnher, E Wagner, H Clausen, et al.

Infection|September 25, 2025

Cutaneous diphtheria in a child returning from visiting friends & relatives in Burkina Faso: a case reportG Pagani, M Ticozzelli, F Bassani, et al.

Antiviral Therapy|June 22, 2001

Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosineS Rusconi, S La Seta Catamancio, P Citterio, et al.

Clinical Immunology and Immunopathology|December 24, 1997

Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressorsS Rusconi, A Berlusconi, L Papagno, et al.

Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:

Pageof 11

Science (New York, N.Y.)|February 11, 1994

Transcriptional activation modulated by homopolymeric glutamine and proline stretchesH P Gerber, K Seipel, O Georgiev, et al.

Minerva Anestesiologica|October 9, 2002

[Cornea donation: role of the local coordinator in monitoring and implementation]G Ciceri, S Vesconi, G Carparelli, et al.

European Journal of Biochemistry|May 1, 1992

Phycobilisome structure in the cyanobacteria Mastigocladus laminosus and Anabaena sp. PCC 7120M Glauser, D A Bryant, G Frank, et al.

Journal of Clinical Microbiology|March 7, 2001

In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposureS La Seta Catamancio, M P De Pasquale, P Citterio, et al.

AIDS Research and Human Retroviruses|October 27, 1998

Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individualsS Rusconi, S Santambrogio, A Di Marco, et al.

Antimicrobial Agents and Chemotherapy|April 1, 1994

Alternating versus continuous drug regimens in combination chemotherapy of human immunodeficiency virus type 1 infection in vitroT Mazzulli, S Rusconi, D P Merrill, et al.

Glycobiology|August 1, 1994

Carbohydrate receptor-mediated gene transfer to human T leukaemic cellsM Thurnher, E Wagner, H Clausen, et al.

Infection|September 25, 2025

Cutaneous diphtheria in a child returning from visiting friends & relatives in Burkina Faso: a case reportG Pagani, M Ticozzelli, F Bassani, et al.

Antiviral Therapy|June 22, 2001

Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosineS Rusconi, S La Seta Catamancio, P Citterio, et al.

Clinical Immunology and Immunopathology|December 24, 1997

Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressorsS Rusconi, A Berlusconi, L Papagno, et al.

Pageof 11